Transcriptomics in Toxicogenomics, Part III: Data Modelling for Risk Assessment DOI Creative Commons
Angela Serra, Michele Fratello, Luca Cattelani

et al.

Nanomaterials, Journal Year: 2020, Volume and Issue: 10(4), P. 708 - 708

Published: April 8, 2020

Transcriptomics data are relevant to address a number of challenges in Toxicogenomics (TGx). After careful planning exposure conditions and preprocessing, the TGx can be used predictive toxicology, where more advanced modelling techniques applied. The large volume molecular profiles produced by omics-based technologies allows development application artificial intelligence (AI) methods TGx. Indeed, publicly available omics datasets constantly increasing together with plethora different that made facilitate their analysis, interpretation generation accurate stable models. In this review, we present state-of-the-art applied transcriptomics We show how benchmark dose (BMD) analysis data. review read across adverse outcome pathways (AOP) methodologies. discuss network-based approaches successfully employed clarify mechanism action (MOA) or specific biomarkers exposure. also describe main AI methodologies create classification regression models current challenges. Finally, short description deep learning (DL) integration these contexts. Modelling represents valuable tool for chemical safety assessment. This is third part three-article series on Toxicogenomics.

Language: Английский

Machine learning for high performance organic solar cells: current scenario and future prospects DOI
Asif Mahmood, Jin‐Liang Wang

Energy & Environmental Science, Journal Year: 2020, Volume and Issue: 14(1), P. 90 - 105

Published: Nov. 26, 2020

In this review, current research status about the machine learning use in organic solar cell is reviewed. We have discussed challenges anticipating data driven material design.

Language: Английский

Citations

310

In Silico ADME/Tox Profiling of Natural Products: A Focus on BIOFACQUIM DOI Creative Commons
Noemi Angeles Durán-Iturbide, Bárbara I. Díaz‐Eufracio, José L. Medina‐Franco

et al.

ACS Omega, Journal Year: 2020, Volume and Issue: 5(26), P. 16076 - 16084

Published: June 25, 2020

Natural products continue to be major sources of bioactive compounds and drug candidates not only because their unique chemical structures but also overall favorable metabolism pharmacokinetic properties. The number publicly accessible natural product databases has increased significantly in the past few years. However, systematic ADME/Tox profile been reported on a limited basis. For instance, BIOFACQUIM was recently published as public database from Mexico, country with rich source biomolecules. its reported. Herein, we discuss results an in-depth silico other large collections products. It concluded that absorption distribution profiles are similar those approved drugs, while is comparable databases. excretion different predicted toxicity comparable. This work further contributes deeper characterization therapeutic potential.

Language: Английский

Citations

156

Leveraging artificial intelligence in the fight against infectious diseases DOI Open Access
Felix Wong, César de la Fuente‐Núñez, James J. Collins

et al.

Science, Journal Year: 2023, Volume and Issue: 381(6654), P. 164 - 170

Published: July 13, 2023

Despite advances in molecular biology, genetics, computation, and medicinal chemistry, infectious disease remains an ominous threat to public health. Addressing the challenges posed by pathogen outbreaks, pandemics, antimicrobial resistance will require concerted interdisciplinary efforts. In conjunction with systems synthetic artificial intelligence (AI) is now leading rapid progress, expanding anti-infective drug discovery, enhancing our understanding of infection accelerating development diagnostics. this Review, we discuss approaches for detecting, treating, diseases, underscoring progress supported AI each case. We suggest future applications how it might be harnessed help control outbreaks pandemics.

Language: Английский

Citations

154

The evolving role of investigative toxicology in the pharmaceutical industry DOI Creative Commons
François Pognan, Mario Beilmann, Harrie C. M. Boonen

et al.

Nature Reviews Drug Discovery, Journal Year: 2023, Volume and Issue: 22(4), P. 317 - 335

Published: Feb. 13, 2023

For decades, preclinical toxicology was essentially a descriptive discipline in which treatment-related effects were carefully reported and used as basis to calculate safety margins for drug candidates. In recent years, however, technological advances have increasingly enabled researchers gain insights into toxicity mechanisms, supporting greater understanding of species relevance translatability humans, prediction events, mitigation side development biomarkers. Consequently, investigative (or mechanistic) has been gaining momentum is now key capability the pharmaceutical industry. Here, we provide an overview current status field using case studies discuss potential impact ongoing developments, based on survey toxicologists from 14 European-based medium-sized large companies. Investigative tools strategies are companies reduce safety-related attrition development. This Perspective article summarizes goals toxicology, highlights approaches discusses selected emerging technologies that improve safety-testing paradigm.

Language: Английский

Citations

132

Big data and machine learning for materials science DOI Creative Commons
José F. Rodrigues, Larisa Florea, Maria Cristina Ferreira de Oliveira

et al.

Discover Materials, Journal Year: 2021, Volume and Issue: 1(1)

Published: April 19, 2021

Herein, we review aspects of leading-edge research and innovation in materials science that exploit big data machine learning (ML), two computer concepts combine to yield computational intelligence. ML can accelerate the solution intricate chemical problems even solve otherwise would not be tractable. However, potential benefits come at cost production; is, algorithms demand large volumes various natures from different sources, material properties sensor data. In survey, propose a roadmap for future developments with emphasis on computer-aided discovery new analysis sensing compounds, both prominent fields context science. addition providing an overview recent advances, elaborate upon conceptual practical limitations applied science, outlining processes, discussing pitfalls, reviewing cases success failure.

Language: Английский

Citations

106

Artificial Intelligence in Drug Toxicity Prediction: Recent Advances, Challenges, and Future Perspectives DOI
Thi Tuyet Van Tran, Agung Surya Wibowo, Hilal Tayara

et al.

Journal of Chemical Information and Modeling, Journal Year: 2023, Volume and Issue: 63(9), P. 2628 - 2643

Published: April 26, 2023

Toxicity prediction is a critical step in the drug discovery process that helps identify and prioritize compounds with greatest potential for safe effective use humans, while also reducing risk of costly late-stage failures. It estimated over 30% candidates are discarded owing to toxicity. Recently, artificial intelligence (AI) has been used improve toxicity as it provides more accurate efficient methods identifying potentially toxic effects new before they tested human clinical trials, thus saving time money. In this review, we present an overview recent advances AI-based prediction, including various machine learning algorithms deep architectures, six major properties Tox21 assay end points. Additionally, provide list public data sources useful tools research community highlight challenges must be addressed enhance model performance. Finally, discuss future perspectives prediction. This review can aid researchers understanding pave way discovery.

Language: Английский

Citations

103

Quantum machine learning for chemistry and physics DOI Creative Commons
Manas Sajjan, Junxu Li, Raja Selvarajan

et al.

Chemical Society Reviews, Journal Year: 2022, Volume and Issue: 51(15), P. 6475 - 6573

Published: Jan. 1, 2022

Machine learning (ML) has emerged into formidable force for identifying hidden but pertinent patterns within a given data set with the objective of subsequent generation automated predictive behavior. In recent years, it is safe to conclude that ML and its close cousin deep (DL) have ushered unprecedented developments in all areas physical sciences especially chemistry. Not only classical variants , even those trainable on near-term quantum hardwares been developed promising outcomes. Such algorithms revolutionzed material design performance photo-voltaics, electronic structure calculations ground excited states correlated matter, computation force-fields potential energy surfaces informing chemical reaction dynamics, reactivity inspired rational strategies drug designing classification phases matter accurate identification emergent criticality. this review we shall explicate subset such topics delineate contributions made by both computing enhanced machine over past few years. We not present brief overview well-known techniques also highlight their using statistical insight. The foster exposition aforesaid empower promote cross-pollination among future-research chemistry which can benefit from turn potentially accelerate growth algorithms.

Language: Английский

Citations

93

Machine Learning for Perovskite Solar Cells and Component Materials: Key Technologies and Prospects DOI
Yiming Liu, Xinyu Tan, Jie Liang

et al.

Advanced Functional Materials, Journal Year: 2023, Volume and Issue: 33(17)

Published: Feb. 15, 2023

Abstract Data‐driven epoch, the development of machine learning (ML) in materials and device design is an irreversible trend. Its ability efficiency to handle nonlinear game‐playing problems unmatched by traditional simulation computing software trial‐error experiments. Perovskite solar cells are complex physicochemical devices (systems) that consist perovskite materials, transport layer electrodes. Predicting properties screening component related strong point ML. However, applications ML has only begun boom last two years, so it necessary provide a review involved technologies, application status, facing urgent challenges blueprint.

Language: Английский

Citations

81

Artificial Intelligence for Drug Discovery: Are We There Yet? DOI

Catrin Hasselgren,

Tudor I. Oprea

The Annual Review of Pharmacology and Toxicology, Journal Year: 2023, Volume and Issue: 64(1), P. 527 - 550

Published: Sept. 22, 2023

Drug discovery is adapting to novel technologies such as data science, informatics, and artificial intelligence (AI) accelerate effective treatment development while reducing costs animal experiments. AI transforming drug discovery, indicated by increasing interest from investors, industrial academic scientists, legislators. Successful requires optimizing properties related pharmacodynamics, pharmacokinetics, clinical outcomes. This review discusses the use of in three pillars discovery: diseases, targets, therapeutic modalities, with a focus on small molecule drugs. technologies, generative chemistry, machine learning, multi-property optimization, have enabled several compounds enter trials. The scientific community must carefully vet known information address reproducibility crisis. full potential can only be realized sufficient ground truth appropriate human intervention at later pipeline stages.

Language: Английский

Citations

75

Revolutionizing drug formulation development: The increasing impact of machine learning DOI
Zeqing Bao,

Jack Bufton,

Riley J. Hickman

et al.

Advanced Drug Delivery Reviews, Journal Year: 2023, Volume and Issue: 202, P. 115108 - 115108

Published: Sept. 27, 2023

Language: Английский

Citations

53